What development phase is Fluoprostenol in?

Fluoprostenol is FDA-approved (marketed).

What is the generic name of Fluoprostenol?

FLUPROSTENOL is the generic (nonproprietary) name of Fluoprostenol.

Last reviewed 2026-04-20 · How we verify

Fluoprostenol (FLUPROSTENOL)

FDA-approved active Small molecule Quality 10/100

At a glance

Generic name	FLUPROSTENOL
Target	Prostaglandin E2 receptor EP3 subtype, Prostaglandin F2-alpha receptor
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Fluoprostenol CI brief — competitive landscape report
Fluoprostenol updates RSS · CI watch RSS